Rallis India Ltd (RALLIS)
🎯 Key Takeaways
- Rallis India is in a strategic transition phase, shifting focus from export-dependent growth to domestic resilience amid monsoon volatility and global headwinds. Management is prioritizing margin discipline, crop diversification (rice, maize, millet), and biologicals expansion, while navigating export softness and competitive pressures in agrochemicals.
- Revenue declined 19.2% QoQ to ₹508 in Q4FY22.
- ⚠️ Dependence on monsoon and domestic agricultural cycles introduces earnings volatility, with management explicitly citing uncertainty in crop patterns.
📖 The Story
Rallis India is in a strategic transition phase, shifting focus from export-dependent growth to domestic resilience amid monsoon volatility and global headwinds. Management is prioritizing margin discipline, crop diversification (rice, maize, millet), and biologicals expansion, while navigating export softness and competitive pressures in agrochemicals.
📰 What's Happening
In Q1 FY27, revenue grew 7% YoY to ₹1,022 crore, driven by 19% domestic growth and 18% crop protection revenue growth to ₹455 crore, despite a 28% export decline to ₹110 crore due to European softness and Chinese competition. EBITDA surged 23% to ₹184 crore, supporting management's target of 15%+ EBITDA margins. Management highlighted stabilized raw material costs and expects mid-to-high single-digit seed growth (excluding cotton) and improved biologicals growth. A CFO transition saw Bhaskar Swaminathan resign effective November 4, 2026, with Sridhar Radhakrishnan appointed, carrying no immediate financial impact but signaling internal restructuring within the Tata ecosystem.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 |
|---|---|---|---|---|
| Revenue | 741 | 728 | 628 | 508 |
| Operating Profit | 103 | 70 | 49 | -23 |
| OPM % | 13.9% | 9.7% | 7.8% | -4.4% |
| Net Profit | 82 | 56 | 40 | -14 |
| EPS | ₹4.23 | ₹2.90 | ₹2.03 | ₹-0.73 |
The company reversed from losses in early 2021 (e.g., ₹-14 crore OP in Mar 2022) to consistent profitability, with OPM improving from -4.4% in Mar 2022 to 13.9% in Jun 2021, reflecting operational stabilization. However, the recent 7% YoY revenue growth in Q1 FY27 masks underlying export weakness, as domestic growth (19%) offsets declining overseas sales. The 23% EBITDA surge underscores margin resilience, but the lack of export recovery and reliance on monsoon-dependent crops introduce earnings volatility, making margin expansion a critical near-term focus.
🔮 Management Outlook & What's Next
Management targets 6-8% growth in agrochemicals, 15%+ EBITDA margins, and significant improvement in biologicals growth amid monsoon uncertainty. They emphasize cautious export recovery, pricing discipline, and strategic shifts toward domestic staple crops (rice, maize, millet) to mitigate global volatility. No forward guidance was provided on revenue or margin expectations beyond these strategic pillars, with management focusing on execution resilience rather than quantitative forecasts.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2021 | Mar 2021 | Mar 2022 | Mar 2022 |
|---|---|---|---|---|
| Equity Capital | 19 | 19 | 19 | 19 |
| Reserves | 1,519 | 1,571 | 1,650 | 1,677 |
| Borrowings | 50 | 76 | 96 | 58 |
| Total Liabilities | 2,661 | 2,589 | 2,851 | 2,858 |
| Fixed Assets | 416 | 424 | 448 | 845 |
| Investments | 366 | 283 | 228 | 212 |
| Total Assets | 2,661 | 2,589 | 2,851 | 2,858 |
The balance sheet remains conservative, with equity of ₹19 crore and reserves of ₹1,677 crore as of Mar 2022, indicating strong capital reserves. Borrowings are minimal at ₹58 crore, suggesting limited leverage and low financial risk. Total assets of ₹2,858 crore have remained stable, reflecting disciplined capital allocation with no major capex or investment spikes disclosed, aligning with a focus on operational efficiency over aggressive expansion.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2022 |
|---|---|
| Operating | +166 |
| Investing | -104 |
| Financing | -61 |
| Net Cash Flow | +0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 55.1% | 55.1% | 55.1% | 55.1% |
| FII | 14.2% | 12.1% | 11.6% | 9.1% |
| DII | 11.2% | 11.3% | 11.3% | 11.7% |
| Public | 14.7% | 16.9% | 17.4% | 19.4% |
| # Shareholders | 1,26,636 | 1,35,010 | 1,29,225 | 1,30,812 |
Promoter holding remains stable at 55.08%, but FII allocation has declined from 14.2% in Q2FY26 to 9.12% in Q1FY27, while DII rose from 11.3% to 11.72%. The drop in FII ownership may reflect reduced institutional confidence amid export headwinds and sector volatility, despite stable promoter stakes. The growing DII presence suggests domestic institutional accumulation, potentially signaling long-term conviction in the company's turnaround narrative.
⚖️ Peer Comparison — Agro Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| UPL | 47,485 | 23.3 | 11.4% | 6.7% | 0.64 |
| PIIND | 36,382 | 31.2 | 13.3% | 10.4% | 0.02 |
| SUMICHEM | 25,753 | 44.4 | 23.1% | 17.1% | 0.00 |
| BAYERCROP | 17,844 | 369.7 | 3.3% | 1.2% | 0.00 |
| SHARDACROP | 6,918 | 11.1 | 25.8% | 20.0% | 0.00 |
| DHANUKA | 4,360 | 14.9 | 27.5% | 21.2% | 0.03 |
| RALLIS | 4,041 | 24.6 | 12.9% | 9.7% | 0.03 |
| NACLIND | 3,988 | 340.5 | 6.0% | 1.8% | 0.44 |
| BHAGCHEM | 3,683 | 134.0 | 6.1% | 3.9% | 0.33 |
| GSPCROP | 2,976 | 26.0 | 22.5% | 21.9% | 0.66 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Dependence on monsoon and domestic agricultural cycles introduces earnings volatility, with management explicitly citing uncertainty in crop patterns. 2. Persistent export weakness due to European softness and Chinese competition could constrain top-line growth, as seen in the 28% YoY export decline. 3. Margin expansion relies on pricing discipline and cost control, but raw material stabilization is not guaranteed amid global commodity fluctuations. 4. Leadership transition in finance function, while operationally neutral, may introduce execution risks if new CFO lacks sector-specific depth.
📋 Recent Filings
-
Announcement 26 August 2026Rallis India announced its September 2026 schedule of analyst and institutional investor meetings, including one-on-one sessions with major funds and ...
-
🟡 Board Meeting 20 August 2026Rallis India announced the resignation of CFO Bhaskar Swaminathan effective November 4, 2026, and appointed Sridhar Radhakrishnan as his successor, fo...
-
🟡 Board Meeting 20 August 2026No summary available
-
🟡 Board Meeting 20 August 2026Rallis India announced the resignation of CFO Bhaskar Swaminathan effective November 4, 2026, following his move to another Tata Group company, and ap...
-
Announcement 10 August 2026Rallis India Limited announced its August 2026 schedule of one-on-one investor meetings with institutional analysts, including engagements with Tata A...
-
🟡 Board Meeting 27 July 2026Rallis India announced the appointment of S R B C & CO LLP as its new statutory auditor for five consecutive years starting from the 2027 AGM through ...
-
🔴 Financial Results 27 July 2026Rallis India reported Q1 FY27 revenue of ₹1,022 crore, up 7% YoY, driven by 19% domestic growth and 7% crop care expansion, while exports fell 28% due...
-
🟡 Board Meeting 22 July 2026Rallis India announced the completion of second consecutive terms for Independent Directors Ms. Padmini Khare Kaicker and Dr. C. V. Natraj, effective ...
-
Announcement 21 July 2026Rallis India Limited announced a scheduled one-on-one meeting with Whiteoak Capital on July 24, 2026, in Singapore, as part of its analyst and institu...
-
🟡 Board Meeting 20 July 2026Rallis India's board approved unaudited Q1 FY26 results showing revenue of **₹1,035 crores**, up from **₹969 crores** in Q1 FY25, with net profit of *...
🧠 Analyst's Read
Rallis India is executing a strategic pivot toward domestic resilience and margin resilience amid volatile exports, but growth remains tethered to monsoon outcomes and global agrochemical dynamics. Investors should monitor export recovery trends, biologicals traction, and margin sustainability beyond the current base case.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when RALLIS files new disclosures
Track RALLIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track RALLIS — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd